Online First

March 08, 2021

Epidemiology
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Anja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, Saskia Lawson-Tovey, Jean W Liew, Lotta Ljung, Elsa F Mateus, Christophe Richez, Maria J Santos, Gabriela Schmajuk, Carlo A Scirè, Emily Sirotich, Jeffrey A Sparks, Paul Sufka, Thierry Thomas, Laura Trupin, Zachary S Wallace, Sarah Al-Adely, Javier Bachiller-Corral, Suleman Bhana, Patrice Cacoub, Loreto Carmona, Ruth Costello, Wendy Costello, Laure Gossec, Rebecca Grainger, Eric Hachulla, Rebecca Hasseli, Jonathan S Hausmann, Kimme L Hyrich, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Lianne Kearsley-Fleet, Philip C Robinson, Jinoos Yazdany, Pedro M Machado COVID-19 Global Rheumatology Alliance

doi: 10.1136/annrheumdis-2020-219498

March 04, 2021

Correspondence response
Response to: ‘Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement’’ by Banday et al
Free

Peter Nash, Josef S Smolen

doi: 10.1136/annrheumdis-2021-219919
Correspondence
Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement’
Free

Aaqib Zaffar Banday, Ankur Kumar Jindal, Surjit Singh

doi: 10.1136/annrheumdis-2021-219890
Letter
Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab
Free

Marcia A Friedman, Kevin L Winthrop

doi: 10.1136/annrheumdis-2021-220088

March 03, 2021

Animal models
Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren’s syndrome-like phenotype in mice

Hiroyuki Nakamura, Tsutomu Tanaka, Thomas Pranzatelli, Youngmi Ji, Hongen Yin, Paola Perez, Sandra A Afione, Shyh-Ing Jang, Corrine Goldsmith, Chang Yu Zheng, William D Swaim, Blake M Warner, Noriyuki Hirata, Masayuki Noguchi, Tatsuya Atsumi, John A Chiorini

doi: 10.1136/annrheumdis-2020-219649
Editorial
Rheumatology and COVID-19 at 1 year: facing the unknowns

Leonard Calabrese, Kevin L Winthrop

doi: 10.1136/annrheumdis-2021-219957
Correspondence
Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’
Free

Zaid Jibri, Ummugulsum Gazel, Dilek Solmaz, Gizem Ayan, Jacob Karsh, Sibel Zehra Aydin, Marcos Sampaio

doi: 10.1136/annrheumdis-2021-220008
Correspondence response
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles
Free

Josef S Smolen

doi: 10.1136/annrheumdis-2021-220164
Correspondence response
Response to: ‘Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’’ by Jibri et al
Free

Walter P Maksymowych, Robert GW Lambert, Mikkel Østergaard, Xenofon Baraliakos

doi: 10.1136/annrheumdis-2021-220078

March 01, 2021

Letter
Patient research partner involvement in rheumatology clinical trials: analysis of journal articles 2016–2020

Huixin Wang, Sarah Stewart, Ben Darlow, Ben Horgan, Graham Hosie, Jane Clark, Nicola Dalbeth

doi: 10.1136/annrheumdis-2021-220138
Correspondence
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
Free

Ben Mulhearn

doi: 10.1136/annrheumdis-2021-220099
Letter
Onset of rheumatoid arthritis after COVID-19: coincidence or connected?
Free

Veerle F A M Derksen, Theresa Kissel, Femke B G Lamers-Karnebeek, Arie E van der Bijl, Annemarie C Venhuizen, Tom W J Huizinga, René E M Toes, Anna H E Roukens, Diane van der Woude

doi: 10.1136/annrheumdis-2021-219859
Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
Free

Martin Schäfer, Anja Strangfeld, Kimme L Hyrich, Loreto Carmona, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Laure Gossec, Philip C Robinson, Jinoos Yazdany, Pedro M Machado

doi: 10.1136/annrheumdis-2021-220134

February 23, 2021

Correspondence response
Response to: ‘Correspondence on ‘Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment’’ by Pamuk and Hasni
Free

Lyna Kamintsky, Steven D Beyea, John D Fisk, Javeria A Hashmi, Antonina Omisade, Cynthia Calkin, Tim Bardouille, Chris Bowen, Maher Quraan, Arnold Mitnitski, Kara Matheson, Alon Friedman, John G Hanly

doi: 10.1136/annrheumdis-2021-220057
Correspondence
Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’
Free

Rui Gao, Lang Qin

doi: 10.1136/annrheumdis-2021-220092
Correspondence response
Response to: ‘Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’’ by Gao and Qin
Free

Maria G Tektonidou, Angela Tincani, Michael M Ward

doi: 10.1136/annrheumdis-2021-220116
Letter
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists
Free

Roberta Priori, Greta Pellegrino, Serena Colafrancesco, Cristiano Alessandri, Fulvia Ceccarelli, Manuela Di Franco, Valeria Riccieri, Rossana Scrivo, Antonio Sili Scavalli, Francesca Romana Spinelli, Fabrizio Conti

doi: 10.1136/annrheumdis-2021-220059
Correspondence
Correspondence on ‘Blood–brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment’
Free

Omer Nuri Pamuk, Sarfaraz Hasni

doi: 10.1136/annrheumdis-2021-220031
Epidemiology
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Free

Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling The ARTIS Study Group

doi: 10.1136/annrheumdis-2021-219845
Letter
Bone loss in patients with SAPHO syndrome: a preliminary study

Xiao Chen, Miaomiao Wang, Wenjing Cui, Zhongqiu Wang

doi: 10.1136/annrheumdis-2021-219917
Correspondence response
Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’’ by Zheng
Free

Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Tjeerd P van Staa, Annelies Boonen, Frank de Vries

doi: 10.1136/annrheumdis-2021-219856
Letter
Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology

Takako Saeki, Tasuku Nagasawa, Yoshifumi Ubara, Yoshinori Taniguchi, Motoko Yanagita, Shinichi Nishi, Michio Nagata, Yutaka Yamaguchi, Takao Saito, Hitoshi Nakashima, Mitsuhiro Kawano

doi: 10.1136/annrheumdis-2020-219510

February 22, 2021

Correspondence response
Response to: ‘Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’’ by Ruscitti et al
Free

Joshua F Baker, Bryant R England, Ted R Mikuls

doi: 10.1136/annrheumdis-2021-220114
Correspondence
Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’
Free

Piero Ruscitti, Giorgio Sesti, Paola Cipriani, Roberto Gerli, Roberto Giacomelli

doi: 10.1136/annrheumdis-2021-220047
Letter
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)

Daniel J Wallace, Florence Figueras, William A Wegener, David M Goldenberg

doi: 10.1136/annrheumdis-2020-219803
Autoinflammatory disorders
Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features

Daniella Muallem Schwartz, Moses M Kitakule, Brian LP Dizon, Cristhian Gutierrez-Huerta, Sarah A Blackstone, Aarohan M Burma, Aran Son, Natalie Deuitch, Sofia Rosenzweig, Hirsh Komarow, Deborah L Stone, Anne Jones, Michele Nehrebecky, Patrycja Hoffmann, Tina Romeo, Adriana Almeida de Jesus, Sara Alehashemi, Megha Garg, Sofia Torreggiani, Gina A Montealegre Sanchez, Katelin Honer, Gema Souto Adeva, Karyl S Barron, Ivona Aksentijevich, Amanda K Ombrello, Raphaela Goldbach-Mansky, Daniel L Kastner, Joshua D Milner, Pamela Frischmeyer-Guerrerio

doi: 10.1136/annrheumdis-2020-219137
Rheumatoid arthritis
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study

Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Tjeerd P van Staa, Annelies Boonen, Frank de Vries

doi: 10.1136/annrheumdis-2020-218758

February 18, 2021

Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers
Free

Pedro M Machado, Martin Schäfer, Anja Strangfeld, Laure Gossec, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Loreto Carmona, Kimme L Hyrich, Philip C Robinson, Jinoos Yazdany

doi: 10.1136/annrheumdis-2021-220058
Correspondence
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
Free

Laurent Arnaud, Hervé Devilliers

doi: 10.1136/annrheumdis-2021-220037
Recommendation
‘SMASH’ recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models

Silvia Hayer, Margriet J Vervoordeldonk, Maria C Denis, Marietta Armaka, Markus Hoffmann, Johan Bäcklund, Kutty Selva Nandakumar, Birgit Niederreiter, Christina Geka, Anita Fischer, Nina Woodworth, Stephan Blüml, George Kollias, Rikard Holmdahl, Florence Apparailly, Marije I Koenders

doi: 10.1136/annrheumdis-2020-219247

February 16, 2021

Correspondence response
Response to ‘Correspondence on ‘Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis’’ by Reuter et al
Free

Chanakya Sharma, Samuel Whittle, Pari Delir Haghighi, Frada Burstein, Helen Isobel Keen

doi: 10.1136/annrheumdis-2020-219815
Correspondence
Correspondence on ‘Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis’
Free

Katja Reuter, Elena Rocca

doi: 10.1136/annrheumdis-2020-219776
Correspondence
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’
Free

Maria De Santis, Antonio Voza, Victor Savevski, Salvatore Badalamenti, Maurizio Cecconi, Alberto Mantovani, Carlo Selmi

doi: 10.1136/annrheumdis-2021-220044
Correspondence response
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by De Santis et al
Free

Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé

doi: 10.1136/annrheumdis-2021-220077

February 15, 2021

Correspondence
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’
Free

Pierre Charles

doi: 10.1136/annrheumdis-2021-219986
Miscellaneous
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider

Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis G McGonagle, Pedro M Machado

doi: 10.1136/annrheumdis-2020-219725
Correspondence response
Response to: ’Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles
Free

Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé

doi: 10.1136/annrheumdis-2021-220001

February 10, 2021

Rheumatoid arthritis
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

Bernard Combe, Alan Kivitz, Yoshiya Tanaka, Désirée van der Heijde, J Abraham Simon, Herbert S B Baraf, Uma Kumar, Franziska Matzkies, Beatrix Bartok, Lei Ye, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Mark C Genovese, Neelufar Mozaffarian, Robert B M Landewé, Sang-Cheol Bae, Edward C Keystone, Peter Nash

doi: 10.1136/annrheumdis-2020-219214
Systemic lupus erythematosus
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

Martin Aringer, Ralph Brinks, Thomas Dörner, David Daikh, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen, David Jayne, R Cervera, Nathalie Costedoat-Chalumeau, Betty Diamond, Dafna D Gladman, Bevra Hahn, Falk Hiepe, Søren Jacobsen, Dinesh Khanna, Kirsten Lerstrøm, Elena Massarotti, Joseph McCune, Guillermo Ruiz-Irastorza, Jorge Sanchez-Guerrero, Matthias Schneider, Murray Urowitz, George Bertsias, Bimba F Hoyer, Nicolai Leuchten, Gabriela Schmajuk, Chiara Tani, Sara K Tedeschi, Zahi Touma, Branimir Anic, Florence Assan, Tak Mao Chan, Ann Elaine Clarke, Mary K Crow, László Czirják, Andrea Doria, Winfried Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter M Izmirly, Michelle Jung, Gábor Kumánovics, Xavier Mariette, Ivan Padjen, José M Pego-Reigosa, Juanita Romero-Diaz, Íñigo Rúa-Figueroa, Raphaèle Seror, Georg H Stummvoll, Yoshiya Tanaka, Maria G Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J Wallace, Sule Yavuz, Pier Luigi Meroni, Marvin J Fritzler, Ray Naden, Karen Costenbader, Sindhu R Johnson

doi: 10.1136/annrheumdis-2020-219373
Pain
Maintaining musculoskeletal health using a behavioural therapy approach: a population-based randomised controlled trial (the MAmMOTH Study)

Gary J Macfarlane, Marcus Beasley, Neil Scott, Huey Chong, Paul McNamee, John McBeth, Neil Basu, Philip C Hannaford, Gareth T Jones, Phil Keeley, Gordon J Prescott, Karina Lovell

doi: 10.1136/annrheumdis-2020-219091
Rheumatoid arthritis
Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study

Hieronymus TW Smeele, Esther Röder, Hetty M Wintjes, Laura JC Kranenburg-van Koppen, Johanna MW Hazes, Radboud JEM Dolhain

doi: 10.1136/annrheumdis-2020-219547
Systemic lupus erythematosus
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

Christina Adamichou, Irini Genitsaridi, Dionysis Nikolopoulos, Myrto Nikoloudaki, Argyro Repa, Alessandra Bortoluzzi, Antonis Fanouriakis, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias

doi: 10.1136/annrheumdis-2020-219069

February 09, 2021

Thinking the unthinkable
Rheumatology in 2049: the age of all data

Johanna Mucke, Philipp Sewerin, Matthias Schneider

doi: 10.1136/annrheumdis-2020-219686
Viewpoint
EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs

Johannes WJ Bijlsma

doi: 10.1136/annrheumdis-2020-219773

February 08, 2021

Correspondence
Correspondence on ‘Cardiovascular effects of biological versus csDMARD therapy in treatment naive, early rheumatoid arthritis’
Free

Athanasios N Georgiadis, Eleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos

doi: 10.1136/annrheumdis-2021-219891
Correspondence
Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’
Free

Bing-kun Zheng

doi: 10.1136/annrheumdis-2020-219797
Correspondence response
Response to: ‘Correspondence on ‘Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis’’ by Georgiadis et al
Free

Sven Plein, Maya H Buch

doi: 10.1136/annrheumdis-2021-219926

February 05, 2021

Correspondence response
Response to: ‘Correspondence on ‘Bowman’s capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications’’ by Hakroush and Tampe
Free

Vincenzo L'Imperio, Gisella Vischini, Manuel Ferraro, Fabio Pagni

doi: 10.1136/annrheumdis-2021-219988
Early arthritis
Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA: a large cross-sectional MRI study

Xanthe Marijn Edmée Matthijssen, Fenne Wouters, Navkiran Sidhu, Ellis Niemantsverdriet, Annette van der Helm-van Mil

doi: 10.1136/annrheumdis-2020-219302
Correspondence
Correspondence on ‘Bowman’s capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications’
Free

Samy Hakroush, Björn Tampe

doi: 10.1136/annrheumdis-2021-219970

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

March 08, 2021

March 04, 2021

March 03, 2021

March 01, 2021

February 23, 2021

February 22, 2021

February 18, 2021

February 16, 2021

February 15, 2021

February 10, 2021

February 09, 2021

February 08, 2021

February 05, 2021

Pages